Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip to Host Meetings at the Mizuho Investor Conference
DENVER , Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,
Toggle Summary BioScrip Announces Additions to Senior Leadership Team
Appoints Harriet Booker as Senior Vice President, Chief Operating Officer and Danny R. Claycomb as Senior Vice President, Revenue Cycle Management DENVER , Nov. 28, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of
Toggle Summary BioScrip to Present at Bank of America Merrill Lynch 2017 Leveraged Finance Conference
DENVER , Nov. 16, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen Deitsch ,
Toggle Summary BioScrip to Host Meetings at the 8th Annual Craig-Hallum Alpha Select Conference
DENVER , Nov. 09, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen Deitsch , Senior Vice President, Chief Financial Officer and Treasurer and
Toggle Summary BioScrip Reports Third Quarter 2017 Financial Results
– Net revenue of $198.7 million , including core product mix of 75.0%, compared to 65.8% in the prior year – Net revenue and adjusted EBITDA reduced $10.0 million and $3.0 million , respectively, due to sales disruption from Hurricane Irma, Hurricane Harvey, and completion of the UnitedHealthcare
Toggle Summary BioScrip to Present at Stephens Fall Investment Conference
DENVER , Oct. 31, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Stephen Deitsch , Senior Vice President, Chief Financial Officer and Treasurer and
Toggle Summary BioScrip to Host Third Quarter Results Call
DENVER , Oct. 16, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will release its third quarter 2017 financial results on Thursday,
Toggle Summary BioScrip Announces Availability of ALS Home Infusion Therapy
DENVER , Oct. 05, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, is pleased to announce that it can now dispense and administer Radicava® (edaravone), the first treatment
Toggle Summary BioScrip Reports Second Quarter 2017 Financial Results
– Net revenue of $218.1 million , including core product mix of 73.1% compared to 60.3% in the prior year – Net loss from continuing operations of $28.7 million , compared to $8.3 million in the prior year, reflecting increased non-cash expenses and interest – Adjusted EBITDA of $10.0 million ,
Toggle Summary BioScrip Applauds US House Passage of HR3178, the Medicare Part B Improvement Act of 2017
Legislation Accelerates Medicare Payment of Home Infusion Therapy Services to 2019 DENVER , July 26, 2017 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the US